haloperidol has been researched along with ubiquinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beppu, Y; Ishida, Y; Saito, T; Shuto, K | 1 |
| Andreassen, OA; Jørgensen, HA; Weber, C | 1 |
| Banerjee, S; Das, SK; Dubey, S; Lahiri, D; Roy, BK; Sawale, VM | 1 |
3 other study(ies) available for haloperidol and ubiquinone
| Article | Year |
|---|---|
Effects of OM-853, a novel indolonaphthyridine derivative, on behavioral responses in the forced swim test in rats.
Topics: Animals; Behavior, Animal; Benzoquinones; Haloperidol; Imipramine; Immobilization; Male; Motor Activity; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Swimming; Ubiquinone; Vinca Alkaloids | 1993 |
Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Biological Availability; Brain; Coenzymes; Dyskinesia, Drug-Induced; Haloperidol; Male; Motor Activity; Mouth; Rats; Rats, Sprague-Dawley; Ubiquinone | 1999 |
Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report.
Topics: Adolescent; Anti-Dyskinesia Agents; Chorea; DNA, Mitochondrial; Genetic Testing; Haloperidol; Humans; Male; MELAS Syndrome; Micronutrients; Point Mutation; Treatment Outcome; Ubiquinone | 2019 |